AGGRESSIVE LYMPHOMA
Clinical trials for AGGRESSIVE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE LYMPHOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody therapy aims to prevent lymphoma return after transplant
Disease control Recruiting nowThis early-phase study tests whether adding a drug called mosunetuzumab after a stem cell transplant is safe and doable for people with aggressive B cell lymphoma that has come back or not responded to prior treatments. Mosunetuzumab is an engineered antibody that helps the body'…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Can early palliative care boost quality of life for blood cancer patients?
Symptom relief Recruiting nowThis study looks at whether adding early palliative care to usual treatment helps people with multiple myeloma or aggressive B-cell lymphoma feel better. About 144 patients and their caregivers will either get early palliative care plus standard care or standard care alone. Resea…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC